Physician profile
Michael Anthony Edwards
NPI 1013967884
$7,646.35
in general payments reported to CMS, 2019-2025
10 companies · $407 in 2025
The $407 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,451 · 2020: $112 · 2021: $33.89 · 2022: $636 · 2023: $575 · 2024: $4,431 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,068 · Food and Beverage: $1,516 · Travel and Lodging: $820 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,068.49 |
| Food and Beverage | $1,515.70 |
| Travel and Lodging | $819.84 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,466.58 | 2019-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $278.07 | 2021-2024 | Signia |
| Zimmer Biomet Holdings, INC. | $214.34 | 2019 | |
| Novo Nordisk INC | $132.36 | 2023 | |
| Boston Scientific Corporation | $124.90 | 2023 | Watchman Access System |
| Medical Device Business Services, INC. | $119.98 | 2022 | |
| Horizon Therapeutics Plc | $111.91 | 2020 | |
| Karl Storz Endoscopy-America | $107.12 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Integra Lifesciences Corporation | $22.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.